Estimation of the Quality of Life Benefits Associated With Treatment for Spinal Muscular Atrophy

ClinicoEconomics and Outcomes Research - New Zealand
doi 10.2147/ceor.s214084
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Operative Treatment for Hip Subluxation in Spinal Muscular Atrophy

The Journal of Bone and Joint Surgery. British volume
2005English

Carrier Screening for Spinal Muscular Atrophy

Genetics in Medicine
MedicineGenetics
2008English

Novel Therapeutic Strategies for Spinal Muscular Atrophy

Future Neurology
Neurology
2015English

Pnd41 - Healthcare Costs of Patients With Spinal Muscular Atrophy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Spinal Muscular Atrophy Type 1

Pediatric Critical Care Medicine
Child HealthCritical CarePediatricsPerinatologyIntensive Care Medicine
2012English

Characteristic of the Spinal Muscular Atrophy Cell Model

2019English

Spinal Muscular Atrophy With Preserved Deep Tendon Reflexes

Indian Journal of Pediatrics
Child HealthPediatricsPerinatology
2017English

Respiratory Management of the Infant With Type 1 Spinal Muscular Atrophy

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2005English

Who Influences Parents’ Decision on Life Support Treatments for Children With Spinal Muscular Atrophy Type 1?

Pediatric Dimensions
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy